Consensus Moderna, Inc.

Equities

MRNA

US60770K1079

Real-time Estimate Cboe BZX 10:27:41 2024-05-14 am EDT 5-day change 1st Jan Change
129.3 USD +2.92% Intraday chart for Moderna, Inc. +6.49% +29.64%

Evolution of the average Target Price on Moderna, Inc.

Price target over the last 5 years

History of analyst recommendation changes

bf49a96f1e1402faee06bf81.dyFrrUO3gXK3_qyBJaNfy9S4oyM2jevv_GWoGFH185k.Qmci4jLy1TjAqoHySfEtmI350lZVy62eijLrVDeasuxBaSjUNdjuBtuL4Q~633740effe27d01907b80a7d19088ef4
Investors need more than PPI to make up their minds Our Logo
ANALYST RECOMMENDATIONS : Nike, Roblox, Starbucks, Walmart, Deckers Outdoor... Our Logo
Evercore ISI Initiates Moderna With In Line Rating, $120 Price Target MT
Moderna Insider Sold Shares Worth $1,825,220, According to a Recent SEC Filing MT
Deutsche Bank Raises Moderna's Price Target to $85 From $70 MT
UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating MT
News Highlights : Top Financial Services News of the Day - Monday at 11 AM ET DJ
Moderna Insider Sold Shares Worth $1,663,855, According to a Recent SEC Filing MT
Jefferies Adjusts Price Target on Moderna to $155 From $125 MT
Oppenheimer Adjusts Price Target on Moderna to $163 From $142 MT
Goldman Sachs Adjusts Price Target on Moderna to $204 From $206 MT
Leerink Adjusts Price Target on Moderna to $60 From $59 MT
Morgan Stanley Adjusts Price Target on Moderna to $95 From $89 MT
Jefferies & Co Adjusts Moderna Price Target to $155 From $125 MT
Goldman Sachs Adjusts Moderna Price Target to $204 From $206 MT
Morgan Stanley Raises Price Target on Moderna to $95 From $89, Keeps Equalweight Rating MT
RBC Raises Price Target on Moderna to $135 From $125 on 'More Prudent Financial Outlook,' Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : Alphabet, Amgen, Starbucks, PayPal, Moderna... Our Logo
MODERNA : price target raised by Oddo BHF CF
RBC Raises Price Target on Moderna to $135 From $125 MT
Chardan Research Lowers Metagenomi's PT to $17 From $21 on Heels of Announced Termination of Collaboration With Moderna, Keeps Buy Rating MT
Moderna Secures Contract to Supply 12.5 Million COVID-19 Vaccine Doses to Brazil MT
Moderna Insider Sold Shares Worth $1,575,300, According to a Recent SEC Filing MT
Redburn Adjusts Moderna's Price Target to $117 From $110 MT
MODERNA : Jefferies confirms its Buy recommendation CF
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
125.7 USD
Average target price
138.5 USD
Spread / Average Target
+10.22%
High Price Target
310 USD
Spread / Highest target
+146.68%
Low Price Target
60 USD
Spread / Lowest Target
-52.26%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Moderna, Inc.

Evercore ISI
Deutsche Bank Securities
UBS
Jefferies & Co.
Oppenheimer
Goldman Sachs
Leerink Partners
Morgan Stanley
RBC Capital Markets
Redburn
HSBC
Canaccord Genuity
RBC Luca Issi
JPMorgan Chase
Argus
TD Cowen
William Blair & Co.
Guggenheim
SVB Securities LLC
Cowen
Chardan Research
Piper Sandler
SVB Leerink
BofA Securities
Wolfe Research
Barclays
Chardan
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
  1. Stock Market
  2. Equities
  3. MRNA Stock
  4. Consensus Moderna, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW